Lab greening – how you can play your part! Una FitzGerald, Galway Neuroscience Centre, Founder - 'Galway Green Labs' initiative Dr FitzGerald will share her motivation for getting involved in promoting and implementing green lab practices at first, within her own University in Galway, and then, across Ireland and Europe. She will describe the experience ... Read more
Development and applications of photoswitchable small molecules and peptides to control protein-protein interactions and GPCR activity Davia Prischich, Nanoprobes and Nanoswitches group, IBEC The defense will be held online through the platform provided by the UB. For those who are interested in joining, please remember that you have to write an email to vd.quimica.recerca@ub.edu at least 48 hours before the event.
Nano Rare Diseases Day es un evento organizado en el marco del Día Mundial de las Enfermedades Minoritarias donde se darán a conocer las últimas innovaciones en materia de Nanomedicina para el tratamiento y diagnóstico de dichas enfermedades, con temas que van desde el diagnóstico precoz, la liberación controlada de fármacos o el desarrollo de nuevas terapia Durante esta jornada, ... Read more
Emmarcat dins del cicle (Re)Imaginem Barcelona, Barcelona Tribuna reuneix Jordi Marin, director general de l’Associació Catalana d’Empreses Consultores (ACEC); Josep Samitier, director de l’Institut de Bioenginyeria de Catalunya; Núria Bayó, cap de programes acadèmics i eficàcia organitzativa del Barcelona Institute of Science and Technology (BIST); i Alexis Roig, director del SciTech DiploHub, per parlar de “La innovació, la gestió del ... Read more
Compartmentalised microfluidic culture systems for in vitro modelling of neurological and neuromuscular microenvironments Maider Badiola, Nanobioengineering group Movement of skeletal-muscle fibres is generated by the locomotion circuit. Failures in any part of the circuit can cause or define the severity of neuromuscular diseases (NMD), such as amyotrophic lateral sclerosis (ALS). Conventional in vitro study models ... Read more
Breaking Paradigms: Delivering insulin orally Ester Caffarel, MIT Biologics have revolutionized disease treatment; however, their rapid degradation and poor absorption in the gastrointestinal (GI) tract generally limit their administration to parenteral routes. Devices for the oral delivery of biologics must aid in both localization and permeation to achieve systemic drug uptake. For this purpose, we ... Read more
Membraneless compartments based on intrinsically disordered proteins: from biology towards new protein materials Paolo Arosio, Institute for Chemical and Bioengineering, ETH Zurich In the last few years, discoveries in biology are revealing that a class of intrinsically disordered protein sequences plays an important role in the formation of cellular membraneless compartments by spontaneous liquid-liquid phase ... Read more
Diabetes, where are we? Anna Novials, PI of the group “Pathogenesis and Prevention of Diabetes” at IDIBAPS/Clinic Hospital of Barcelona and member of CIBERDEM network. Diabetes mellitus (DM) is a group of chronic metabolic disorders all characterized by hyperglycemia. It occurs either when the pancreas does not produce enough insulin or when the peripheral tissues ... Read more
Subjective ratings of emotive stimuli predict the impact of the COVID-19 quarantine on affective states Héctor López Carral, SPECS lab, IBEC The COVID-19 crisis resulted in a large proportion of the world’s population having to employ social distancing measures and self-quarantine. Given that limiting social interaction impacts mental health, we assessed the effects of quarantine on emotive perception ... Read more
Developing new strategies to understand human kidney development and target human disease Patricia Prado Peralta, Pluripotency for organ regeneration group The defence will take place online using the BBCollab platform